HEADER IMMUNE SYSTEM 12-JAN-21 7DV6 TITLE DISCOVERY OF FUNCTIONALLY SELECTIVE TRANSFORMING GROWTH FACTOR BETA TITLE 2 TYPE II RECEPTOR (TGF-BETA RII) INHIBITORS AS ANTI-FIBROSIS AGENTS COMPND MOL_ID: 1; COMPND 2 MOLECULE: TGF-BETA RECEPTOR TYPE-2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: TGFR-2,TGF-BETA TYPE II RECEPTOR,TRANSFORMING GROWTH FACTOR- COMPND 5 BETA RECEPTOR TYPE II,TBETAR-II; COMPND 6 EC: 2.7.11.30; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TGFBR2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.NISHIHATA,A.NOMURA,S.MIWA,S.DOI,T.ADACHI REVDAT 2 29-NOV-23 7DV6 1 REMARK REVDAT 1 16-JUN-21 7DV6 0 JRNL AUTH S.MIWA,M.YOKOTA,Y.UEYAMA,K.MAEDA,Y.OGOSHI,N.SEKI,N.OGAWA, JRNL AUTH 2 J.NISHIHATA,A.NOMURA,T.ADACHI,Y.KITAO,K.NOZAWA,T.ISHIKAWA, JRNL AUTH 3 Y.UKAJI,M.SHIOZAKI JRNL TITL DISCOVERY OF SELECTIVE TRANSFORMING GROWTH FACTOR BETA TYPE JRNL TITL 2 II RECEPTOR INHIBITORS AS ANTIFIBROSIS AGENTS. JRNL REF ACS MED.CHEM.LETT. V. 12 745 2021 JRNL REFN ISSN 1948-5875 JRNL PMID 34055221 JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00679 REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 14345 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.163 REMARK 3 R VALUE (WORKING SET) : 0.160 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 762 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.39 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.45 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1052 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.91 REMARK 3 BIN R VALUE (WORKING SET) : 0.1920 REMARK 3 BIN FREE R VALUE SET COUNT : 56 REMARK 3 BIN FREE R VALUE : 0.2290 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2405 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 202 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.37000 REMARK 3 B22 (A**2) : -1.33000 REMARK 3 B33 (A**2) : -3.05000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.328 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.234 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.148 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.985 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2510 ; 0.012 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3413 ; 2.143 ; 1.648 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 883 ; 1.842 ; 1.100 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 127 ;33.453 ;23.150 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 432 ;15.150 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;15.738 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 323 ; 0.189 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1911 ; 0.019 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1230 ; 2.911 ; 3.348 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1541 ; 4.446 ; 5.004 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1280 ; 3.953 ; 3.539 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 10806 ; 8.904 ;59.099 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 240 A 543 REMARK 3 ORIGIN FOR THE GROUP (A): 17.122 6.405 13.723 REMARK 3 T TENSOR REMARK 3 T11: 0.0029 T22: 0.1259 REMARK 3 T33: 0.0774 T12: 0.0128 REMARK 3 T13: 0.0018 T23: 0.0029 REMARK 3 L TENSOR REMARK 3 L11: 0.8856 L22: 1.3554 REMARK 3 L33: 0.8901 L12: -0.0671 REMARK 3 L13: 0.1148 L23: 0.0734 REMARK 3 S TENSOR REMARK 3 S11: -0.0005 S12: 0.0236 S13: -0.0167 REMARK 3 S21: 0.0043 S22: -0.0049 S23: 0.1497 REMARK 3 S31: -0.0408 S32: -0.0476 S33: 0.0055 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7DV6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1300020166. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-JUN-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5-9.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 4M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15148 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 48.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.27000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5E8V REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12-22% PEG4000,3% ETHYLENE GLYCOL,16% REMARK 280 GLYCEROL, 160 MM MGCL2, 80 MM TRISHCL AT PH 7.5-9.3,THE 9.2 MG/ REMARK 280 ML OF TGFBETARII PROTEIN WAS INCUBATED WITH 1MM COMPOUND AT 277K REMARK 280 FOR 1-2 HR, VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.98650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.99000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.00400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.99000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.98650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.00400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 235 REMARK 465 ALA A 236 REMARK 465 HIS A 237 REMARK 465 ASN A 238 REMARK 465 THR A 239 REMARK 465 LEU A 544 REMARK 465 ASP A 545 REMARK 465 ARG A 546 REMARK 465 LEU A 547 REMARK 465 SER A 548 REMARK 465 GLY A 549 REMARK 465 LEU A 550 REMARK 465 GLU A 551 REMARK 465 HIS A 552 REMARK 465 HIS A 553 REMARK 465 HIS A 554 REMARK 465 HIS A 555 REMARK 465 HIS A 556 REMARK 465 HIS A 557 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 254 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 542 CG CD OE1 OE2 REMARK 470 HIS A 543 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 378 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 CYS A 394 N - CA - CB ANGL. DEV. = -12.6 DEGREES REMARK 500 ARG A 403 CG - CD - NE ANGL. DEV. = 14.4 DEGREES REMARK 500 ARG A 479 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 247 -63.08 -104.09 REMARK 500 LEU A 308 -61.59 -93.29 REMARK 500 ARG A 378 -4.11 74.77 REMARK 500 ASP A 379 42.34 -145.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 LEU A 299 10.19 REMARK 500 ALA A 310 12.63 REMARK 500 SER A 383 10.47 REMARK 500 VAL A 464 10.83 REMARK 500 SER A 476 18.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HJF A 9000 DBREF 7DV6 A 237 549 UNP P37173 TGFR2_HUMAN 237 549 SEQADV 7DV6 MET A 235 UNP P37173 INITIATING METHIONINE SEQADV 7DV6 ALA A 236 UNP P37173 EXPRESSION TAG SEQADV 7DV6 ALA A 431 UNP P37173 GLU 431 ENGINEERED MUTATION SEQADV 7DV6 ALA A 433 UNP P37173 ARG 433 ENGINEERED MUTATION SEQADV 7DV6 ALA A 485 UNP P37173 GLU 485 ENGINEERED MUTATION SEQADV 7DV6 ALA A 488 UNP P37173 LYS 488 ENGINEERED MUTATION SEQADV 7DV6 ALA A 493 UNP P37173 ARG 493 ENGINEERED MUTATION SEQADV 7DV6 ALA A 495 UNP P37173 ARG 495 ENGINEERED MUTATION SEQADV 7DV6 LEU A 550 UNP P37173 EXPRESSION TAG SEQADV 7DV6 GLU A 551 UNP P37173 EXPRESSION TAG SEQADV 7DV6 HIS A 552 UNP P37173 EXPRESSION TAG SEQADV 7DV6 HIS A 553 UNP P37173 EXPRESSION TAG SEQADV 7DV6 HIS A 554 UNP P37173 EXPRESSION TAG SEQADV 7DV6 HIS A 555 UNP P37173 EXPRESSION TAG SEQADV 7DV6 HIS A 556 UNP P37173 EXPRESSION TAG SEQADV 7DV6 HIS A 557 UNP P37173 EXPRESSION TAG SEQRES 1 A 323 MET ALA HIS ASN THR GLU LEU LEU PRO ILE GLU LEU ASP SEQRES 2 A 323 THR LEU VAL GLY LYS GLY ARG PHE ALA GLU VAL TYR LYS SEQRES 3 A 323 ALA LYS LEU LYS GLN ASN THR SER GLU GLN PHE GLU THR SEQRES 4 A 323 VAL ALA VAL LYS ILE PHE PRO TYR GLU GLU TYR ALA SER SEQRES 5 A 323 TRP LYS THR GLU LYS ASP ILE PHE SER ASP ILE ASN LEU SEQRES 6 A 323 LYS HIS GLU ASN ILE LEU GLN PHE LEU THR ALA GLU GLU SEQRES 7 A 323 ARG LYS THR GLU LEU GLY LYS GLN TYR TRP LEU ILE THR SEQRES 8 A 323 ALA PHE HIS ALA LYS GLY ASN LEU GLN GLU TYR LEU THR SEQRES 9 A 323 ARG HIS VAL ILE SER TRP GLU ASP LEU ARG LYS LEU GLY SEQRES 10 A 323 SER SER LEU ALA ARG GLY ILE ALA HIS LEU HIS SER ASP SEQRES 11 A 323 HIS THR PRO CYS GLY ARG PRO LYS MET PRO ILE VAL HIS SEQRES 12 A 323 ARG ASP LEU LYS SER SER ASN ILE LEU VAL LYS ASN ASP SEQRES 13 A 323 LEU THR CYS CYS LEU CYS ASP PHE GLY LEU SER LEU ARG SEQRES 14 A 323 LEU ASP PRO THR LEU SER VAL ASP ASP LEU ALA ASN SER SEQRES 15 A 323 GLY GLN VAL GLY THR ALA ARG TYR MET ALA PRO GLU VAL SEQRES 16 A 323 LEU ALA SER ALA MET ASN LEU GLU ASN VAL GLU SER PHE SEQRES 17 A 323 LYS GLN THR ASP VAL TYR SER MET ALA LEU VAL LEU TRP SEQRES 18 A 323 GLU MET THR SER ARG CYS ASN ALA VAL GLY GLU VAL LYS SEQRES 19 A 323 ASP TYR GLU PRO PRO PHE GLY SER LYS VAL ARG GLU HIS SEQRES 20 A 323 PRO CYS VAL ALA SER MET ALA ASP ASN VAL LEU ALA ASP SEQRES 21 A 323 ALA GLY ARG PRO GLU ILE PRO SER PHE TRP LEU ASN HIS SEQRES 22 A 323 GLN GLY ILE GLN MET VAL CYS GLU THR LEU THR GLU CYS SEQRES 23 A 323 TRP ASP HIS ASP PRO GLU ALA ARG LEU THR ALA GLN CYS SEQRES 24 A 323 VAL ALA GLU ARG PHE SER GLU LEU GLU HIS LEU ASP ARG SEQRES 25 A 323 LEU SER GLY LEU GLU HIS HIS HIS HIS HIS HIS HET HJF A9000 26 HETNAM HJF 5-[(3S)-5,5-DIMETHYLOXOLAN-3-YL]-6-METHOXY-3-(2- HETNAM 2 HJF METHOXYPYRIDIN-4-YL)PYRAZOLO[1,5-A]PYRIMIDINE FORMUL 2 HJF C19 H22 N4 O3 FORMUL 3 HOH *202(H2 O) HELIX 1 AA1 GLU A 283 SER A 295 1 13 HELIX 2 AA2 ASP A 296 LYS A 300 5 5 HELIX 3 AA3 ASN A 332 HIS A 340 1 9 HELIX 4 AA4 SER A 343 SER A 363 1 21 HELIX 5 AA5 LYS A 381 SER A 383 5 3 HELIX 6 AA6 SER A 409 GLY A 417 1 9 HELIX 7 AA7 THR A 421 MET A 425 5 5 HELIX 8 AA8 ALA A 426 ALA A 431 1 6 HELIX 9 AA9 ASN A 438 GLU A 440 5 3 HELIX 10 AB1 SER A 441 ARG A 460 1 20 HELIX 11 AB2 CYS A 461 GLY A 465 5 5 HELIX 12 AB3 CYS A 483 LEU A 492 1 10 HELIX 13 AB4 PRO A 501 ASN A 506 5 6 HELIX 14 AB5 HIS A 507 TRP A 521 1 15 HELIX 15 AB6 ASP A 524 ARG A 528 5 5 HELIX 16 AB7 THR A 530 LEU A 541 1 12 SHEET 1 AA1 5 ILE A 244 LYS A 252 0 SHEET 2 AA1 5 GLU A 257 LEU A 263 -1 O LYS A 262 N GLU A 245 SHEET 3 AA1 5 GLU A 272 PRO A 280 -1 O GLU A 272 N LEU A 263 SHEET 4 AA1 5 LYS A 319 THR A 325 -1 O TYR A 321 N PHE A 279 SHEET 5 AA1 5 PHE A 307 LYS A 314 -1 N LEU A 308 O ILE A 324 SHEET 1 AA2 2 ILE A 375 VAL A 376 0 SHEET 2 AA2 2 LEU A 402 ARG A 403 -1 O LEU A 402 N VAL A 376 SHEET 1 AA3 2 ILE A 385 VAL A 387 0 SHEET 2 AA3 2 CYS A 393 LEU A 395 -1 O CYS A 394 N LEU A 386 SITE 1 AC1 15 VAL A 250 VAL A 258 ALA A 275 LYS A 277 SITE 2 AC1 15 LEU A 305 THR A 325 ALA A 326 PHE A 327 SITE 3 AC1 15 HIS A 328 GLY A 331 ASN A 332 SER A 383 SITE 4 AC1 15 LEU A 386 CYS A 396 HOH A9117 CRYST1 61.973 76.008 77.980 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016136 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013157 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012824 0.00000